{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:18:24Z","timestamp":1793416704989,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1124\/jpet.122.001455","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T22:35:11Z","timestamp":1678401311000},"page":"205-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Molecule ent-Verticilide"],"prefix":"10.1016","volume":"385","author":[{"given":"Daniel J.","family":"Blackwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail N.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tri","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Gochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Schmeckpeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey R.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendell S.","family":"Akers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4956-9735","authenticated-orcid":false,"given":"Bjorn C.","family":"Knollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001455_bib1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/0929867024606731","article-title":"Converting a peptide into a drug: strategies to improve stability and bioavailability","volume":"9","author":"Adessi","year":"2002","journal-title":"Curr Med Chem"},{"key":"10.1124\/jpet.122.001455_bib2","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1073\/pnas.1816685116","article-title":"Unnatural verticilide enantiomer inhibits type 2 ryanodine receptor-mediated calcium leak and is antiarrhythmic","volume":"116","author":"Batiste","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.122.001455_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"10.1124\/jpet.122.001455_bib4","doi-asserted-by":"crossref","first-page":"14093","DOI":"10.1073\/pnas.1002713107","article-title":"Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic","volume":"107","author":"Bird","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.122.001455_bib5","series-title":"Goodman & Gilman\u2019s the Pharmacological Basis of Therapeutics","author":"Brunton","year":"2023"},{"key":"10.1124\/jpet.122.001455_bib6","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/chem.201905385","article-title":"Cyclic peptides as drugs for intracellular targets: the next frontier in peptide therapeutic development","volume":"27","author":"Buckton","year":"2021","journal-title":"Chemistry"},{"key":"10.1124\/jpet.122.001455_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/acsmedchemlett.0c00581","article-title":"Steering new drug discovery campaigns: permeability, solubility, and physicochemical properties in the bRo5 chemical space","volume":"12","author":"Caron","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/jpet.122.001455_bib8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s40262-013-0079-0","article-title":"Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides","volume":"52","author":"Diao","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.122.001455_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jat.727","article-title":"A good practice guide to the administration of substances and removal of blood, including routes and volumes","volume":"21","author":"Diehl","year":"2001","journal-title":"J Appl Toxicol"},{"key":"10.1124\/jpet.122.001455_bib10","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/CIRCRESAHA.114.300568","article-title":"Role of RyR2 phosphorylation in heart failure and arrhythmias: Controversies around ryanodine receptor phosphorylation in cardiac disease","volume":"114","author":"Dobrev","year":"2014","journal-title":"Circ Res"},{"key":"10.1124\/jpet.122.001455_bib11","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1002\/anie.201107204","article-title":"Enantiomeric natural products: occurrence and biogenesis","volume":"51","author":"Finefield","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/jpet.122.001455_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF01746203","article-title":"The role of Ca2+ release from sarcoplasmic reticulum in the regulation of sinoatrial node automaticity","volume":"11","author":"Hata","year":"1996","journal-title":"Heart Vessels"},{"key":"10.1124\/jpet.122.001455_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1399-3011.1989.tb00707.x","article-title":"Conformations, cation binding, and transmembrane ion transfer properties of a cyclooctapeptide built by an alternation of D and L residues","volume":"34","author":"Heitz","year":"1989","journal-title":"Int J Pept Protein Res"},{"key":"10.1124\/jpet.122.001455_bib14","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/acs.jmedchem.7b00318","article-title":"The current state of peptide drug discovery: back to the future?","volume":"61","author":"Henninot","year":"2018","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.122.001455_bib15","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1021\/acs.chemrev.0c00013","article-title":"Strategies for fine-tuning the conformations of cyclic peptides","volume":"120","author":"Jwad","year":"2020","journal-title":"Chem Rev"},{"key":"10.1124\/jpet.122.001455_bib16","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1093\/ehjcvp\/pvab069","article-title":"Advances in the understanding of excitation-contraction coupling: the pulsing quest for drugs against heart failure and arrhythmias","volume":"7","author":"Kansakar","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1124\/jpet.122.001455_bib17","first-page":"2510","article-title":"Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia","volume":"116","author":"Knollmann","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.122.001455_bib18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nature06799","article-title":"A genetic framework for improving arrhythmia therapy","volume":"451","author":"Knollmann","year":"2008","journal-title":"Nature"},{"key":"10.1124\/jpet.122.001455_bib19","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1080\/17460441.2021.1942837","article-title":"Recent advances in proteolytic stability for peptide, protein, and antibody drug discovery","volume":"16","author":"Lai","year":"2021","journal-title":"Expert Opin Drug Discov"},{"key":"10.1124\/jpet.122.001455_bib20","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCRESAHA.117.310083","article-title":"Calcium signaling and cardiac arrhythmias","volume":"120","author":"Landstrom","year":"2017","journal-title":"Circ Res"},{"key":"10.1124\/jpet.122.001455_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.18433\/J3GP53","article-title":"Understanding the hysteresis loop conundrum in pharmacokinetic\/pharmacodynamic relationships","volume":"17","author":"Louizos","year":"2014","journal-title":"J Pharm Pharm Sci"},{"issue":"67","key":"10.1124\/jpet.122.001455_bib22","first-page":"2771","article-title":"Manual restraint and common compound administration routes in mice and rats","author":"Machholz","year":"2012","journal-title":"J Vis Exp"},{"key":"10.1124\/jpet.122.001455_bib23","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1021\/acs.chemrev.6b00838","article-title":"Orally absorbed cyclic peptides","volume":"117","author":"Nielsen","year":"2017","journal-title":"Chem Rev"},{"key":"10.1124\/jpet.122.001455_bib24","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/jps.21533","article-title":"Improved pharmacokinetic and bioavailability support of drug discovery using serial blood sampling in mice","volume":"98","author":"Peng","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.122.001455_bib25","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1039\/C2MD20203D","article-title":"Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance","volume":"3","author":"Rand","year":"2012","journal-title":"MedChemComm"},{"key":"10.1124\/jpet.122.001455_bib26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1113\/expphysiol.1996.sp003983","article-title":"Possible role of calcium release from the sarcoplasmic reticulum in pacemaking in guinea-pig sino-atrial node","volume":"81","author":"Rigg","year":"1996","journal-title":"Exp Physiol"},{"key":"10.1124\/jpet.122.001455_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ja.2009.126","article-title":"Verticilide, a new ryanodine-binding inhibitor, produced by Verticillium sp. FKI-1033","volume":"63","author":"Shiomi","year":"2010","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1124\/jpet.122.001455_bib28","first-page":"629","article-title":"Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals","volume":"36","author":"Sundberg","year":"1998","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1124\/jpet.122.001455_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1039\/C001463J","article-title":"Fungal cyclooligomer depsipeptides: from classical biochemistry to combinatorial biosynthesis","volume":"28","author":"S\u00fcssmuth","year":"2011","journal-title":"Nat Prod Rep"},{"key":"10.1124\/jpet.122.001455_bib30","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1161\/CIRCULATIONAHA.111.067306","article-title":"Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation","volume":"125","author":"Voigt","year":"2012","journal-title":"Circulation"},{"key":"10.1124\/jpet.122.001455_bib31","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1113\/JP276757","article-title":"Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia","volume":"598","author":"Wleklinski","year":"2020","journal-title":"J Physiol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524004488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524004488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:29:09Z","timestamp":1739971749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524004488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0022356524004488"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001455","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Molecule ent-Verticilide","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}